Infectious Diseases Society of America position paper: recommended revisions to the National Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) sepsis quality measure.
Open accessThe DOI matches its Crossref record; 101 of the 103 references it cites were found in a registry or an index.
Abstract
The Centers for Medicare & Medicaid Services’ Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) measure has appropriately established sepsis as a national priority. However, the Infectious Diseases Society of America (IDSA and five additional endorsing societies) is concerned about SEP-1’s potential to drive antibiotic overuse because it does not account for the high rate of sepsis overdiagnosis and encourages aggressive antibiotics for all patients with possible sepsis, regardless of the certainty of diagnosis or severity of illness. IDSA is also concerned that SEP-1’s complex “time zero” definition is not evidence-based and is prone to inter-observer variation. In this position paper, IDSA outlines several recommendations aimed at reducing the risk of unintended consequences of SEP-1 while maintaining focus on its evidence-based elements. IDSA’s core recommendation is to limit SEP-1 to septic shock, for which the evidence supporting the benefit of immediate antibiotics is greatest. Prompt empiric antibiotics are often appropriate for suspected sepsis without shock, but IDSA believes there is too much heterogeneity and difficulty defining this population, uncertainty about the presence of infection, and insufficient data on the necessity of immediate antibiotics to support a mandatory treatment standard for all patients in this category. IDSA believes guidance on managing possible sepsis without shock is more appropriate for guidelines that can delineate the strengths and limitations of supporting evidence and allow clinicians discretion in applying specific recommendations to individual patients. Removing sepsis without shock from SEP-1 will mitigate the risk of unnecessary antibiotic prescribing for noninfectious syndromes, simplify data abstraction, increase measure reliability, and focus attention on the population most likely to benefit from immediate empiric broad-spectrum antibiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Several professional societies, including the Infectious Diseases Society of America, have recently encouraged regulators and guideline developers to provide more specific direction about which patients with possible sepsis require immediate broad-spectrum antibiotics, which can safely be managed with narrower spectrum regimens, and which can be managed without antibiotics while obtaining further”
From Trends in empiric broad-Spectrum antibiotic use for suspected community-onset Sepsis in US hospitals (2024) · cites this paper as [15]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“The three hour window was chosen to match the treatment window recommended by the Centers for Medicare and Medicaid Services (CMS) sepsis core measure (SEP-1) and the Surviving Sepsis Campaign guidelines 36,62,63 .”
From Factors driving provider adoption of the TREWS machine learning-based early warning system and its effects on sepsis treatment timing (2022) · cites this paper as [63]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The increasing emphasis on administering immediate antibiotics to all patients with possible sepsis may therefore be driving increased use of unnecessarily broad-spectrum antibiotics, antibiotic-associated adverse events, and antimicrobial resistance without benefitting patients.”
From Trends in empiric broad-Spectrum antibiotic use for suspected community-onset Sepsis in US hospitals (2024) · cites this paper as [15]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The third international consensus definitions for sepsis and septic shock (Sepsis-3).
Singer, M., Deutschman, C. S., Seymour, C. W., Shankar-Hari, M., Annane, D., Bauer, M., Bellomo, R., Bernard, G. R., Chiche, J.-D., Coopersmith, C. M., et al. (2016) · JAMA · doi:10.1001/jama.2016.0287 · Cited by 28,250
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock
Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., Jaeschke, R., et al. (2013) · Critical Care Medicine · doi:10.1097/ccm.0b013e31827e83af · Cited by 9,694
The Surviving Sepsis Campaign Guidelines Committee including The Pediatric Subgroup*, Dellinger, R. P., Levy, M. M., Rhodes, A., Annane, D., Gerlach, H., Opal, S. M., Sevransky, J. E., Sprung, C. L., Douglas, I. S., et al. (2013) · Intensive Care Medicine · doi:10.1007/s00134-012-2769-8 · Cited by 7,290
Kumar, A., Roberts, D., Wood, K. E., Light, B., Parrillo, J. E., Sharma, S., Suppes, R., Feinstein, D., Zanotti, S., Taiberg, L., et al. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000217961.75225.e9 · Cited by 6,109 · cited 1×
“IDSA believes a 1-hour treatment target is plausible and justifiable, compared to 3 hours, given the urgency of septic shock [10, 38, 41, 43].”
BackgroundAntibiotic resistance threats in the United States, 2019
(U.S.), C. F. D. C. A. P. (2019) · doi:10.15620/cdc:82532 · Cited by 5,782
Surviving Sepsis Campaign: International guidelines for management of sepsis and septic shock: 2016.
Rhodes, A., Evans, L. E., Alhazzani, W., Levy, M. M., Antonelli, M., Ferrer, R., Kumar, A., Sevransky, J. E., Sprung, C. L., Nunnally, M. E., et al. (2017) · Critical Care Medicine · doi:10.1097/ccm.0000000000002255 · Cited by 3,652
A randomized trial of protocol-based care for early septic shock.
The ProCESS Investigators (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1401602 · Cited by 2,414
Time to treatment and mortality during mandated emergency care for sepsis.
Seymour, C. W., Gesten, F., Prescott, H. C., Friedrich, M. E., Iwashyna, T. J., Phillips, G. S., Lemeshow, S., Osborn, T., Terry, K. M., & Levy, M. M. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1703058 · Cited by 2,225 · cited 5×
“There are 2 major lines of evidence that are used to support the mandated roll-out of bundled sepsis care: (1) before/after studies that demonstrate a reduction in sepsis mortality after bundle implementation [51–56]; and/or (2) studies of association that report lower mortality rates in sepsis patients who received b…”
BackgroundResultInfluentialGoal-Directed Resuscitation for Patients with Early Septic Shock
The ARISE Investigators and the ANZICS Clinical Trials Group (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1404380 · Cited by 2,028
Incidence and trends of sepsis in US hospitals using clinical vs claims data, 2009-2014.
Rhee, C., Dantes, R., Epstein, L., Murphy, D. J., Seymour, C. W., Iwashyna, T. J., Kadri, S. S., Angus, D. C., Danner, R. L., Fiore, A. E., et al. (2017) · JAMA · doi:10.1001/jama.2017.13836 · Cited by 1,884
Self-citation
Cited by
Items 101–200 of 202
Repairing Innovation: A Study of Integrating AI in Clinical Care
Elish, M. C., & Watkins, E. A. (2020) · doi:10.69985/vcvu5761 · Cited by 5
Farsani, A., Thandi, P., & Htway, Z. (2025) · Cureus · doi:10.7759/cureus.90728 · Cited by 6
“Patients met criteria if they had suspected or confirmed infection and at least two systemic inflammatory response syndrome (SIRS) criteria [10].”
InfluentialKadri, S. S., Warner, S., Rhee, C., Klompas, M., Follmann, D. A., Swihart, B., Laxminarayan, R., & Klein, E. Y. (2023) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofad286 · Cited by 5
Self-citationSisto, U. G., Bella, S. D., Porta, E., Franzoi, G., Cominotto, F., Guzzardi, E., Artusi, N., Giudice, C. A., Bo, E. D., Collot, N., et al. (2024) · Journal of Nursing Scholarship · doi:10.1111/jnu.13002 · Cited by 5
Noval, M., Leekha, S., Armahizer, M. J., Celotto, A., Bhatt, M., Seung, H., & Claeys, K. C. (2022) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2022.30 · Cited by 5
Kommareddy, A., Vagha, J. D., & Meshram, R. J. (2023) · Cureus · doi:10.7759/cureus.49870 · Cited by 5
“They are a valuable resource for healthcare professionals seeking nuanced approaches to septic shock care [70].”
BackgroundObermaier, M., Weigand, M. A., Popp, E., & Uhle, F. (2021) · Notfall + Rettungsmedizin · doi:10.1007/s10049-021-00949-y · Cited by 5
“Eine Stellungnahme der European Society of Emergency Medicine (EuSEM) kritisiert die Fixierung auf ein starres „1h bundle“: So sei zwar die frühe Antibiotikagabe eine der wenigen Maßnahmen innerhalb der Sepsisbündel, diemit derMortalität korrelieren, doch solle gleichzeitig eine unnötige Antibiose (und Volumentherapie…”
BackgroundInfluentialSurgical Infection Society Research Priorities: A Narrative Review of Fourteen Years of Progress
Mele, T. S., Kaafarani, H. M. A., Guidry, C. A., Loor, M. M., Machado-Aranda, D., Mendoza, A. E., Morris‐Stiff, G. J., Rattan, R., Schubl, S. D., & Barie, P. S. (2020) · Surgical Infections · doi:10.1089/sur.2020.309 · Cited by 5
“…more recently, the Infectious Diseases Society of America (IDSA) recommended that early antibiotic administration be reserved for patients in septic shock (for which the evidence is greatest) and to use caution in patients with suspected sepsis without shock until the diagnosis is confirmed [43].”
Klompas, M., & Rhee, C. (2021) · Annals of Internal Medicine · doi:10.7326/m21-1571 · Cited by 5
“Others are concerned that the measure's rigid treatment requirements and aggressive timelines encourage excessive fluids and antibiotics, curtail clinicians' latitude to calibrate their management to their certainty of infection and patients' severity of illness, and unduly anchor providers' diagnostic focus on sepsis…”
BackgroundSelf-citationMa, A., Zhang, C., Gong, Y., Ma, X., & Yan, N. (2025) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2025.1491331 · Cited by 4
Significant Publications on Infectious Diseases Pharmacotherapy in 2022
Teran, N. S., Buckley, V., Britt, R. S., Ikwuagwu, J. O., Thomas, J. L., Zaki, A., Olson, K., Stramel, S., & on behalf of the Houston Infectious Diseases Network (2023) · Journal of Pharmacy Practice · doi:10.1177/08971900231194200 · Cited by 4
Fabre, V., Cosgrove, S. E., Milstone, A. M., Salinas, A. B., Degnan, K. O., Gettler, E. B., Glaser, L. J., Johnson, J. K., Moehring, R. W., Nelson, G. E., et al. (2024) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2024.208 · Cited by 4
“22 Another favored potential strategy was the development of a bacteremia risk score.”
Self-citationWendel‐Garcia, P. D., Ceccato, A., Motos, A., Franch-Llasat, D., Pérez-Moreno, M. O., Domenech-Spanedda, M. F., Chamarro-Martí, E., Ferrer, R., Fernández‐Barat, L., Riera, J., et al. (2025) · Journal of Infection · doi:10.1016/j.jinf.2025.106411 · Cited by 4
Challenging the Dogma of Aggressive Initiation of Antibiotics in Sepsis
Guidry, C. A., Sawyer, R. G., & Winfield, R. D. (2020) · Surgical Infections · doi:10.1089/sur.2020.244 · Cited by 4
“If we accept diagnostic uncertainty as part of our sepsis treatment pathway, it becomes clear that our current ‘‘one-size-fits-all’’ approach to antibiotic initiation is unnecessary and may be harmful [10,12].”
Yarrington, M. E., Moehring, R. W., David, M. Z., Hamilton, K. W., Klompas, M., Rhee, C., Hsueh, K., Ashley, E. D., Sinkowitz‐Cochran, R. L., Ryan, M., et al. (2021) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2021.205 · Cited by 4
Self-citationEmpiric Antibiotic Prescribing for Suspected Sepsis: A Stewardship Balancing Act
Pulia, M. S., & Redwood, R. (2020) · The American Journal of the Medical Sciences · doi:10.1016/j.amjms.2020.08.030 · Cited by 4
“Both the Hour-1 bundle and SEP-1 metric have generated significant opposition from those who accurately point out that they exert pressure on ED clinicians to initiate broad-spectrum antibiotics for clinically stable patients who meet nonspecific sepsis criteria that often result in overdiagnosis.(3,13) Also, it is im…”
BackgroundMethodNocturnal Respiratory Rate Dynamics Enable Early Recognition of Impending HospitalizationsPreprint
Harrington, N., Barba, D. T., Bui, Q. M., Wassell, A., Khurana, S., Rubarth, R. B., Sung, K., Owens, R. L., Agnihotri, P., & King, K. R. (2022) · medRxiv · doi:10.1101/2022.03.10.22272238 · Cited by 4
Efficacy of Xuebijing Injection for Sepsis (EXIT-SEP): Lost in Translation
Liao, X., & Rello, J. (2023) · Anaesthesia Critical Care & Pain Medicine · doi:10.1016/j.accpm.2023.101257 · Cited by 4
Zhang, J. Z., Chan, C. H. T., Chang, L. C., Chiu, L. C. S., Ng, P. Y., Dharmangadan, M., Ho, E., Ling, S. K.-H., Man, M. Y., Fong, K. M., et al. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf752 · Cited by 3
“Our data support the guidance from the Surviving Sepsis Campaign and Infectious Diseases Society of America to routinely obtain blood cultures for all patients with suspected sepsis to detect causative bacterial pathogens and facilitate attainment of appropriate antibiotics [28, 34].”
Self-citationOptimal timing of antibiotics administration for sepsis or septic shock in the emergency department
Hsieh, M., Chiu, K.-C., Liao, S.-H., Hsieh, V. C.-R., Hu, S.-Y., & How, C. (2026) · BMC Emergency Medicine · doi:10.1186/s12873-026-01471-5 · Cited by 3
“While the SSC guideline definition of T2A may have been more relevant, it is much more difficult to track in clinical practice, since most cases of sepsis develop insidi-ously [11, 27].”
Diagnosis of sepsis in the emergency department: a real-world analysis from Lombardy, Italy
Bosetti, C., Santucci, C., Signorini, F., Cortellaro, F., Villa, G., Rossi, C., Nattino, G., & Bertolini, G. (2023) · Internal and Emergency Medicine · doi:10.1007/s11739-023-03464-9 · Cited by 3
“Early sepsis recognition is strongly related to quality of care, including prompt initiation of antibiotic treatment and fluid resuscitation, although the optimal timing of antibiotics is still under debate [6–15].”
Quantifying Empiric Antibiotic Use in US Children’s Hospitals
Chiotos, K., D’Arinzo, L., Kitt, E. M., Ross, R. K., & Gerber, J. S. (2021) · Hospital Pediatrics · doi:10.1542/hpeds.2021-005950 · Cited by 3
Self-citationRevealing Landscape of Competing Endogenous RNA Networks in Sepsis-Induced Cardiovascular Diseases
Xiong, W., Feng, S., Zhao, Y., Liu, X., & Gong, J. (2023) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2407214 · Cited by 3
“Early diagnosis and bundled treatment of sepsis within the first few hours can improve long-term outcomes in SCVDs [9].”
BackgroundHill, T. M., Kerivan, L. T., Vilain, K. R., Windham, S., Sarani, N., Simpson, S. Q., & Guidry, C. A. (2025) · Intensive Care Medicine · doi:10.1007/s00134-025-07899-w · Cited by 3
“All times are relative to this starting point [8].”
Bae, E. Y., Smith, T. T., & Monogue, M. L. (2022) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2022.341 · Cited by 3
Availability of Multiple Organ Failure Score Components in Surgical Patients
Braasch, M. C., Halimeh, B. N., & Guidry, C. A. (2022) · Surgical Infections · doi:10.1089/sur.2021.265 · Cited by 3
“For example, the Centers for Medicare and Medicaid Services (CMS) links reimbursement with Severe Sepsis and Septic Shock Early Management Bundle (SEP-1) compliance in patients with sepsis, where the very definition of sepsis now requires the accurate assessment of the SOFA score [15].”
A Wrinkle in Time to Antibiotics in Sepsis: When Should ONE Hour Be the Goal?
Chiotos, K., & Weiss, S. L. (2021) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2021.01.075 · Cited by 3
Self-citationToward More Rational Time-to-Antibiotic Metrics for Suspected Sepsis*
Rhee, C., & Heil, E. L. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004905 · Cited by 3
Self-citationSurveillance: a prerequisite for effective antimicrobial stewardship
ten Oever, J. (2021) · Scandinavian Journal of Infectious Diseases · doi:10.1080/23744235.2021.1910340 · Cited by 3
Association of second antibiotic dose delays on mortality in patients with septic shock
Jabir, Z. H., Grey, T. S., Morelli, A. R., Nornhold, B. D., Carlson, J. N., Thompson, D. V., & Gour, A. (2024) · Journal of Critical Care · doi:10.1016/j.jcrc.2024.154866 · Cited by 2
Taylor, S. P., Palakshappa, J. A., Chou, S., Gibbs, K. W., King, J., Patel, N., & Kowalkowski, M. A. (2024) · Clinical Infectious Diseases · doi:10.1093/cid/ciae445 · Cited by 2
Sepsis: a summary of the SEP-1 quality measure and future considerations
Scherger, S. J., & Kalil, A. C. (2024) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2024.12.019 · Cited by 2
Self-citationImpact of a Sepsis Quality Improvement Initiative on Clinical and Operational Outcomes
Thomas, C. B., Wyler, B., D’Antonio, C., Laperouse, M., Alwood, S. M., Richard, K., Grantham, A., Sheybani, R., Sorrells, M. G., Tan, W.-J., et al. (2025) · Healthcare · doi:10.3390/healthcare13111273 · Cited by 2
“Additionally, current performance measures [9] may lead to inappropriate resource allocation (blood cultures, broad-spectrum antibiotics), diagnostic anchoring [10], and potential harm to patients who have other time-sensitive, life-threatening diseases.”
Lacquaniti, A., Pistolesi, V., Smeriglio, A., Santoro, D., Iannetti, C., Lentini, G., Chimenz, R., Chirico, V., Trombetta, D., Morabito, S., et al. (2025) · Antibiotics · doi:10.3390/antibiotics14111097 · Cited by 2
“The Infectious Diseases Society of America suggests that aggressive antibiotic administration within one hour may not always be beneficial and can lead to inappropriate broad-spectrum use [8,9].”
Antibiotic timing and progression to sepsis among patients in the ED for infection
Lin, X., Liu, C., Chen, F., Xie, H., Xie, A., Wang, L., Chen, C., Wang, Z., Weng, J., & Chen, Y. (2026) · European journal of medical research · doi:10.1186/s40001-026-03971-3 · Cited by 2
“In addition, the Infectious Diseases Society of America (IDSA) opinion states that uniform use of antibiotics in all patients with suspected sepsis increases the risk of antibiotic overuse without apparent benefit [26].”
Zarama, V., Espinola, J. A., & Camargo, C. A. (2026) · Journal of Critical Care · doi:10.1016/j.jcrc.2026.155740 · Cited by 2
Circular RNAs as potential biomarkers for male severe sepsis
Jun, L., Wang, Z., Wang, S., Liao, X., Qin, T., & Guo, W. (2024) · Open Life Sciences · doi:10.1515/biol-2022-0900 · Cited by 2
“Severe sepsis occurs when there are incidences of organ failure, and remains one of the main causes of death in intensive care units [2,3].”
BackgroundCurrent state of sepsis resuscitation in critical care
Orellana, G., Josef, V., Parchim, N. F., & Mitchell, J. A. (2023) · International Anesthesiology Clinics · doi:10.1097/aia.0000000000000416 · Cited by 2
“Multiorgan dysfunction syndrome was defined as the presence of altered organ function in an acutely ill patient such that homeostasis cannot be maintained without intervention.(9)”
BackgroundCausal association of immune effector proteins with sepsis: A Mendelian randomization study
Wang, Y., Xu, C., Zhang, Y., Zhou, L. M., Zhang, T., Yin, X., Wang, X., Jiang, Y., Du, F., & Wang, X. (2024) · Medicine · doi:10.1097/md.0000000000039494 · Cited by 2
“[20] However, studies on the complex mechanisms between sepsis and immune effects are still insufficient.”
BackgroundRhee, C., Filbin, M. R., & Klompas, M. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad105 · Cited by 2
Self-citationWhat Is Left to Tackle in Inpatient Antimicrobial Stewardship Practice and Research
Bork, J. T., & Heil, E. L. (2023) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2023.07.003 · Cited by 2
Self-citationSudat, S. E. K. (2021) · medRxiv · doi:10.1101/2021.05.26.21257894 · Cited by 2
“The Center for Medicare and Medicaid Services (CMS) in the US has also established a quality measure for hospitals based on compliance with a sepsis treatment bundle (SEP-1), although the bundle has received criticism, and there does not appear to be evidence that its implementation resulted in improved outcomes for p…”
“The Early Beta-Lactam Catches the Germ”: Empiric Antimicrobial Sequence in Bloodstream Infections
Cutrell, J. B., & Sanders, J. M. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab871 · Cited by 2
Rhee, C., & Septimus, E. J. (2022) · Critical Care Medicine · doi:10.1097/ccm.0000000000005430 · Cited by 2
Self-citationScientific recommendations for a Belgian Sepsis National Action Plan (Be-SNAP)
Brys, A. D. H., Verthé, C., Duval, E., Verbakel, J. Y. J., Van Bever, J., Morreel, S., Snoeij, T., Malfait, I., Merchie, A., Caluwaerts, A., et al. (2024) · Lirias (KU Leuven) · Cited by 2
Ranard, B. L., Qian, M., Cummings, M. J., Zhang, D. Y., Lee, S. M., Beitler, J. R., Applebaum, J. R., Schenck, E. J., Mohamed, H., Trepp, R., et al. (2025) · BMJ Open · doi:10.1136/bmjopen-2024-088792 · Cited by 1
“39 Given that a SIRS alert should prompt the clinical team to consider sepsis and is not necessarily the time of sepsis recognition, we decided the primary outcome will look at completion of a modified sepsis bundle within 3 hours from the first SIRS alert.”
Ten Clinical Pearls in Microbiology: How Effective Collaboration Optimizes Patient Care
Lam, J. C., & Bourassa‐Blanchette, S. (2024) · The American Journal of Medicine · doi:10.1016/j.amjmed.2024.05.013 · Cited by 1
Lasry, D. E., Lee, T. C., Paquette, K., Demir, K. K., Yansouni, C. P., Sweet, D. D., Cheng, M. P., & Lawandi, A. (2024) · Journal of the Association of Medical Microbiology and Infectious Disease Canada · doi:10.3138/jammi-2024-0024 · Cited by 1
Ryder, J. H., Cawcutt, K. A., Japp, C. A., & Schooneveld, T. C. V. (2025) · Infection Control and Hospital Epidemiology · doi:10.1017/ice.2025.10317 · Cited by 1
Comorbidities, Weight-Based Initial Fluid Resuscitation, and Mortality in Patients With Sepsis
Munroe, E. S., Walzl, E., Seelye, S. M., Cahill, M., Czilok, T., Jones, J., Kenes, M. T., Posa, P., Taylor, S. P., & Prescott, H. C. (2026) · JAMA Network Open · doi:10.1001/jamanetworkopen.2026.18232 · Cited by 1
Yang, B. S. K., Jeong, H., Park, S., Yoon, J. H., Han, M., Suh, G. Y., & Lim, S. Y. (2026) · Scientific Reports · doi:10.1038/s41598-026-62014-3 · Cited by 1
“Based on these findings, there has been a call for entirely removing sepsis without shock subpopulation from the population subject to the bundle 26 .”
Quality and safety in the literature: September 2020
Houchens, N., & Gupta, A. B. (2020) · BMJ Quality & Safety · doi:10.1136/bmjqs-2020-011887 · Cited by 1
Is ‘sepsis’ a failed paradigm?
Boyle, A. A. (2021) · Emergency Medicine Journal · doi:10.1136/emermed-2021-211627 · Cited by 1
Adelman, M. W., Septimus, E. J., & Arias, C. A. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad240 · Cited by 1
Self-citationHeil, E. L., Aitken, S. L., Nix, D. E., Drew, R. H., Rose, W. E., Davis, S. L., Justo, J. A., Fish, D. N., Pogue, J. M., & the Society of Infectious Diseases Pharmacists (2020) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/phar.2384 · Cited by 1
Self-citationCoston, T. D., Wright, S. W., Hantrakun, V., Rudd, K. E., Chamnan, P., Wongsuvan, G., West, T. E., & Limmathurotsakul, D. (2025) · Critical Care Medicine · doi:10.1097/ccm.0000000000006932 · Cited by 1
Cheng, J., Li, Q., Zhang, G., xu, H., Li, Y., Tian, X., Chen, D., & Luo, Z. (2021) · Research Square · doi:10.21203/rs.3.rs-332633/v1 · Cited by 1
Operationalizing Sepsis Definitions With Artificial Intelligence: Toward Smarter Antibiotic Use
Ford, J. S., Gross, B., Nemati, S., Malhotra, A., & Wardi, G. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf601 · Cited by 1
Peled, H. B., Dau, N. Q., & Sanders, S. S. (2021) · Annals of Internal Medicine · doi:10.7326/m20-8266
“The CMS quotes studies in defense of SEP-1 that describe an association between bundle compliance and outcomes (8).”
BackgroundInfluentialCheng, J., Li, Q., Zhang, G., Xu, H., Li, Y., Tian, X., Chen, D., & Luo, Z. (2020) · Research Square · doi:10.21203/rs.3.rs-136343/v1
“The Infectious Diseases Society of America states the administration time of antibiotic varies with different pathogens and populations [13].”
BackgroundBalancing between sepsis, AKI and gentamicin in the emergency department
Cobussen, M. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20210527mc
Sepsis auf deutschen Intensivstationen – Weltweit Schlusslicht? … Nicht so schnell
Bauer, M. W., Groesdonk, H. V., Preissing, F., Dickmann, P., Vogelmann, T., & Gerlach, H. (2021) · Der Anaesthesist · doi:10.1007/s00101-021-00986-9
“In Abwesenheit solcher validenDaten sollten Forderungen nach externenQualitätssicherungsmaßnahmen bei Sepsis, die zuRechtnichtunumstrittensind [21], ausbleiben und bestehende Systeme unter Beachtungder aktuellenLiteratur kritisch bewertet werden.”
BackgroundCMS is only happy when it rains
Fung, C., & Meurer, W. J. (2021) · Academic Emergency Medicine · doi:10.1111/acem.14317
A Stitch in Time: Optimizing Antibiotic Use From the Start*
Chiotos, K., Weiss, S. L., & Gerber, J. S. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000005148
Self-citationQuality and safety in the literature: September 2021
Lopez, A., Gupta, A. B., & Houchens, N. (2021) · BMJ Quality & Safety · doi:10.1136/bmjqs-2021-013891
Evaluation of antibiotic escalation in response to nurse-driven inpatient sepsis screen
Furukawa, D., Dieringer, T. D., Wong, M. D., Tong, J. T., Cader, I. A., Wisk, L. E., Han, M. A., Gupta, S., Kerbel, R. B., Uslan, D. Z., et al. (2021) · Antimicrobial Stewardship & Healthcare Epidemiology · doi:10.1017/ash.2021.232
López‐Cortés, A., Guevara‐Ramírez, P., Kyriakidis, N. C., Barba‐Ostria, C., Cáceres, Á. L., Guerrero, S. X., Munteanu, C. R., Tejera, E., Ortiz‐Prado, E., Cevallos-Robalino, D., et al. (2020) · ChemRxiv · doi:10.26434/chemrxiv.12408074
Shappell, C. N., Klompas, M., & Rhee, C. (2021) · Critical Care Medicine · doi:10.1097/ccm.0000000000004981
Self-citationGuidry, C. A., & Sawyer, R. G. (2022) · Springer eBooks · doi:10.1007/978-3-031-07881-1_34
Emergency Evaluation and Management of Sepsis and Septic Shock
Dillon, K. (2022) · Physician Assistant Clinics · doi:10.1016/j.cpha.2022.08.007
Tidlig antibiotikabehandling til de rette pasientene
Holten, A. R., & Skrede, S. (2023) · Tidsskrift for Den norske legeforening · doi:10.4045/tidsskr.22.0702
Provider Perceptions of Antibiotic Initiation Strategies for Hospital-Acquired Pneumonia
Swilling, A. C., O’Dell, J. C., Beyene, R. T., Watson, C. M., Sawyer, R. G., Chollet‐Hinton, L., Simpson, S. Q., Atchison, L., Derickson, M. J., Cooper, L., et al. (2024) · Surgical Infections · doi:10.1089/sur.2023.310
“13 Our study aims to address this gap by describing both provider adherence and comfort level with two protocols for antibiotic initiation in an ICU setting.”
Estrategia integral de reanimación del paciente con sepsis y shock séptico
del Río-Carbajo, L., Olmo, J. N.-D., Fernández‐Ugidos, P., & Vidal, P. (2022) · Medicina Intensiva (English Edition) · doi:10.1016/j.medine.2022.02.025
impact of timing of antimicrobial therapy on outcome and mortality in severe sepsis and septic shock
Zahra, A. N. (2024) · International Journal of Health Sciences · doi:10.53730/ijhs.v8ns1.14895
Early Blood Pressure Changes in Neonatal Sepsis and the Risk of Mortality
Ali, K., Haque, T., Bahalkani, U., Bhanbhro, B. A., Bharo, M. A., & Ali, F. K. (2024) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v5i10.2424
Phulpoto, A. H., Kumar, M., Aziz, A., Memon, A. Q., Channa, M. A., & Parvez, S. A. (2024) · Pakistan Journal of Health Sciences · doi:10.54393/pjhs.v5i12.2348
The feasibility of antimicrobial lead time as process and quality indicator for hospitals
Helou, R. I., van der Sijs, H., Rizopoulos, D., Vogel, M., Verkaik, N. J., & Verbon, A. (2025) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-025-05085-w
Balancing Innovation in Artificial Intelligence With Practical Sepsis Definitions
Rhee, C., & Klompas, M. (2025) · Clinical Infectious Diseases · doi:10.1093/cid/ciaf602
Self-citationWright, A. K., & Smith, S. P. (2025) · Journal of the American Association of Nurse Practitioners · doi:10.1097/jxx.0000000000001213
Nazer, L. H., & Kalil, A. C. (2025) · Critical Care Medicine · doi:10.1097/ccm.0000000000006973
Self-citationSanguanwit, P., Monthonn, C., Prachanukool, T., & Suttapanit, K. (2022) · Figshare · doi:10.6084/m9.figshare.19418475
Sanguanwit, P., Monthonn, C., Prachanukool, T., & Suttapanit, K. (2022) · Figshare · doi:10.6084/m9.figshare.19418472
Aita, T., Nakagawa, H., Takahashi, S., Naganuma, T., Anan, K., Banno, M., & Hamaguchi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26732611
Aita, T., Nakagawa, H., Takahashi, S., Naganuma, T., Anan, K., Banno, M., & Hamaguchi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26732605
Aita, T., Nakagawa, H., Takahashi, S., Naganuma, T., Anan, K., Banno, M., & Hamaguchi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26732599
Aita, T., Nakagawa, H., Takahashi, S., Naganuma, T., Anan, K., Banno, M., & Hamaguchi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26732602
Aita, T., Nakagawa, H., Takahashi, S., Naganuma, T., Anan, K., Banno, M., & Hamaguchi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26732608
Aita, T., Nakagawa, H., Takahashi, S., Naganuma, T., Anan, K., Banno, M., & Hamaguchi, S. (2024) · Figshare · doi:10.6084/m9.figshare.26732596
Boussina, A. E. (2024) · eScholarship (California Digital Library)
Jiang, H., Xie, Z., Xiang, J., Wang, H., & Liu, Y. (2026) · Medical Science Monitor · doi:10.12659/msm.951586
“With the sepsis management bundle now condensed to a 1-h window[17], the demand for rapid and reliable early screening tools has intensified.”
Improving empirical antibiotic treatment:The role of diagnostic accuracy and surveillance
Ginting, F. S. (. (2023) · Pure Amsterdam UMC
Antibiotic Stewardship for the Intensivist
Hawes, A. M., & Cosgrove, S. E. (2026) · Critical Care Clinics · doi:10.1016/j.ccc.2026.01.004
Self-citationAdvancing Antimicrobial Stewardship With Diagnostic Excellence: The Role of Bayesian Reasoning
Tsalik, E. L., Prasad, N. K., & Fleisher, L. A. (2026) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofag213
“…an Infectious Diseases Society of America (IDSA) position paper on the national severe sepsis and septic shock early management bundle (SEP-1) recommends delaying empiric antibiotics when immediate therapy is not clinically urgent, prioritizing diagnostic assessment over reflexive prescribing [2].”
Papp, M., Turan, C., Kiss, N., Zubek, L., Karim, D. M., ter Hegyi, P., & Molnár, Z. (2026) · BMJ Open · doi:10.1136/bmjopen-2025-115344
“6 32 We plan to monitor the appropriateness (ie, concordance) of the therapy (if the pathogen is susceptible to the given AB regimen).”
Dobrucki, M., Kuc, K. J., Brzezicki, K., Zegadło, K., Cieciora, M., Cieciora, A., Jakubiak, P., Kawiorska, M., Surowiec, J., & Bełcikowska-Skowron, W. R. (2026) · Journal of Education Health and Sport · doi:10.12775/jehs.2026.92.72701
“However, the Infectious Diseases Society of America (IDSA) heavily criticizes the rigidity of the SEP-1 mandate, arguing that a non-individualized approach risks driving iatrogenic fluid overload and inappropriate antibiotic use in ambiguous, non-shock patients 25.”
Achieving SEP-1 Compliance: Common Pitfalls and Pearls from the Emergency Department
Jia, L. Z., Hyder, E. C., Cocchi, M., Scudder, A. M., Stenson, B. A., Chiu, D. T. W., & Shaw, D. L. (2026) · American Journal of Medical Quality · doi:10.1097/jmq.0000000000000334
Liu, L., Cai, B., & He, B. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1906761
“Fluid resuscitation increases intravascular volume, boosts cardiac output, and improves tissue perfusion; this physiological mechanism serves as the fundamental cornerstone for achieving effective treatment (3).”
Rhee, C., Masur, H., Klompas, M., Bell, T. D., Busch, L. M., Chiotos, K., Classen, D., Gilbert, D., Heil, E. L., Hou, C. H. Y., et al. (2026) · Clinical Infectious Diseases · doi:10.1093/cid/ciag438 · Cited by 2
Self-citationHospital AI and robotics adoption and access inequality in the United States
Johnson, A., Gefen, D., & Harrison, T. (2026) · Scientific Reports · doi:10.1038/s41598-026-70027-1
Metadata
- Authors
- Rhee, C., Chiotos, K., Cosgrove, S. E., Heil, E. L., Kadri, S. S., Kalil, A. C., Gilbert, D. N., Masur, H., Septimus, E. J., Sweeney, D. A., Strich, J. R., Winslow, D. L., & Klompas, M.
- Affiliations
- Brigham and Women's Hospital (US)
- Children's Hospital of Philadelphia (US)
- Johns Hopkins University (US)
- University of Maryland, Baltimore (US)
- National Institutes of Health (US)
- Division of Infectious Diseases, Department of Internal Medicine, University of Nebraska School of Medicine, Omaha, Nebraska, USA
- Oregon Health & Science University (US)
- Harvard University (US)
- University of California San Diego (US)
- Stanford Medicine (US)
- Corresponding author
- Masur, Henry
- ORCID
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2020-05-06
- Volume
- 72
- Issue
- 4
- Pages
- 541-552
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- PMC
- PMC8189682
- OpenAlex
- W3023620462
- Cited by
- 191
- References
- 103
- Citations by year
- 2026: 14 · 2025: 31 · 2024: 36 · 2023: 20 · 2022: 31 · 2021: 47 · 2020: 12
- FWCI
- 19.70
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- National Institutes of Health
- Topics
- Health Sciences › Medicine › Critical Care and Intensive Care Medicine › Sepsis Diagnosis and Treatment
- Health Sciences › Medicine › Infectious Diseases › Antibiotic Use and Resistance
- Health Sciences › Medicine › Microbiology (medical) › Bacterial Identification and Susceptibility Testing
- Keywords
- sepsis, septic shock, Centers for Medicare and Medicaid Services, antibiotic overuse, empirical antibiotic therapy, interobserver variability, broad-spectrum antibiotics
- MeSH terms
- Aged, Anti-Bacterial Agents, Communicable Diseases, Medicare, Humans, Shock, Septic, United States, Reproducibility of Results, Sepsis, Quality Indicators, Health Care
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.